Blake Glen M, Park-Holohan So-Jin, Fogelman Ignac
Department of Nuclear Medicine, Guy's Hospital, London, United Kingdom.
J Nucl Med. 2002 Mar;43(3):338-45.
Quantitative radionuclide studies of bone using the short-lived tracers (18)F-fluoride and (99m)Tc-methylene diphosphonate (MDP) are an alternative method to biochemical markers of bone turnover for investigating the dynamic state of the skeleton. In this study we evaluated their use to quantify bone turnover in women receiving antiresorptive therapy compared with that of untreated control subjects.
The patients were 69 healthy postmenopausal women. Twenty-six women were receiving hormone replacement therapy (HRT) and 43 were untreated age-matched control subjects. After bolus injection of (18)F-fluoride (1 MBq), (99m)Tc-MDP (1 MBq), (51)Cr-ethylenediaminetetraacetic acid (3 MBq), and (125)I-labeled human serum albumin (0.25 MBq), multiple blood samples and urine collections were taken between 0 and 4 h. The clearance to bone mineral K(bone) was first evaluated using the area under the plasma concentration curve (AUC) on the assumption that the rate constant k(4) for the outflow of tracer from bone was negligibly small. AUC values of K(bone) were then compared with those found using a compartmental model method that allowed k(4) to be fitted as a free parameter.
Using the AUC method the mean plus minus SD for K(bone) for the 2 tracers were: (18)F-fluoride, 61.8 plus minus 12.0 mL center dot min(-1) (HRT group) versus 67.2 plus minus 12.6 mL center dot min(-1) (control group) (P = 0.045); and (99m)Tc-MDP, 40.3 plus minus 8.2 mL center dot min(-1) (HRT group) versus 44.2 plus minus 7.6 mL center dot min(-1) (control group) (P = 0.024). Values for the 2 tracers in individual patients were moderately well correlated (r = 0.76; P < 0.001). Using the compartmental model method, k(4) for (18)F-fluoride was shown to lie in the range 0--0.0025 min(-1) with a best-fit value of 0.0018 min(-1). Values of K(bone) determined using k(4) = 0.0018 min(-1) were highly correlated with the AUC values (r = 0.989; SEE = 2.05 mL center dot min(-1)) with numeric values that were larger by a factor of 1.53. Analysis of the (99m)Tc-MDP data was more difficult because of uncertainties in protein binding in the extracellular fluid compartment space. The best fit for k(4) was in the range 0.0010--0.0014 min(-1) with values of K(bone) similar to those found using the AUC method.
Values of K(bone) determined using the AUC method were able to differentiate between HRT-treated women and postmenopausal women who were not treated and were highly correlated with those determined using a compartmental model method with nonzero values of k(4).
使用短寿命示踪剂(18)F - 氟化物和(99m)锝 - 亚甲基二膦酸盐(MDP)进行骨的定量放射性核素研究,是一种用于研究骨骼动态状态的骨转换生化标志物的替代方法。在本研究中,我们评估了它们在接受抗吸收治疗的女性中量化骨转换的用途,并与未治疗的对照受试者进行比较。
患者为69名健康的绝经后女性。26名女性接受激素替代疗法(HRT),43名是年龄匹配的未治疗对照受试者。在静脉推注(18)F - 氟化物(1 MBq)、(99m)Tc - MDP(1 MBq)、(51)Cr - 乙二胺四乙酸(3 MBq)和(125)I标记的人血清白蛋白(0.25 MBq)后,在0至4小时内采集多个血样和尿液样本。首先假设示踪剂从骨流出的速率常数k(4)可忽略不计,使用血浆浓度曲线下面积(AUC)评估骨矿物质摄取率K(bone)。然后将K(bone)的AUC值与使用房室模型方法得到的值进行比较,该方法允许将k(4)作为自由参数进行拟合。
使用AUC方法,两种示踪剂的K(bone)的均值±标准差为:(18)F - 氟化物,61.8±12.0 mL·min-1(HRT组)对67.2±12.6 mL·min-1(对照组)(P = 0.045);以及(99m)Tc - MDP,40.3±8.2 mL·min-1(HRT组)对44.2±7.6 mL·min-1(对照组)(P = 0.024)。个体患者中两种示踪剂的值具有中等程度的相关性(r = 0.76;P < 0.